Brian J C Freeman1, Julia S Kuliwaba, Claire F Jones, Cindy C Shu, Christopher J Colloca, Mohammad R Zarrinkalam, Adnan Mulaibrahimovic, Stan Gronthos, Andrew C W Zannettino, Stuart Howell. 1. *Department of Spinal Surgery, Royal Adelaide Hospital, Adelaide, Australia †Adelaide Centre for Spinal Research, SA Pathology, Adelaide, Australia ‡Centre for Orthopedic and Trauma Research, University of Adelaide, Australia §Raymond Purves Bone and Joint Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Australia ¶College of Health Solutions, Arizona State University, Phoenix, AZ ||School of Medical Sciences, Faculty of Health Science, University of Adelaide, Australia **South Australian Health and Medical Research Institute, Adelaide, Australia ††Discipline of Physiology, School of Medical Sciences, University of Adelaide, Australia ‡‡Data Management and Analysis Centre, University of Adelaide, Adelaide Royal Adelaide Hospital, North Terrace, Adelaide, Australia.
Abstract
STUDY DESIGN: In-vivo ovine model of intervertebral disc degeneration (IVD) to evaluate treatment with stem cells. OBJECTIVE: To determine if stem cells delivered to the nucleus pulposus (NP) or the annulus fibrosus (AF) of degenerated lumbar IVDs leads to improved indices of disc health. SUMMARY OF BACKGROUND DATA: Previous studies assessing the efficacy of stem cell injections into degenerated IVDs have reported positive findings. However, studies have been limited to small animals, targeting solely the NP, with short term follow-up. METHODS: Mesenchymal precursor cells (MSC) were obtained from the iliac crest of 8-week-old sheep. IVD degeneration was induced by postero-lateral annulotomy at three lumbar levels in eight 2-year-old sheep. Six months later, each degenerated IVD was randomized to one of three treatments: Injection of MSC into (i) previously incised AF (AFI), (ii) NP (NPI), or (iii) no injection (negative control, NC). The adjacent IVD received injection of phosphate buffered saline into NP (positive control, PC). Radiographs and magnetic resonance imaging scans were obtained at baseline, 6, 9, and 12 months. Discs were harvested at 12 months for biochemical and histological analyses. RESULTS: IVD degeneration was consistently observed postannulotomy, and characterized by reduced disc height index (DHI), disc height (DH), glycosaminoglycan (GAG) content, and increased grade of disc degeneration.Six months after stem cell injection, DHI and DH had recovered in AFI and NPI groups when compared with NC group (P < 0.01). Mean Pfirrmann grade improved from 3.25 to 2.67 (AFI group) and from 2.96 to 2.43 (NPI group). Mean histopathological grade improved for both AFI (P < 0.002) and NPI (P < 0.02) groups. Both AFI and NPI groups demonstrated spontaneous repair of the postero-lateral annular lesion. CONCLUSION: In this large animal model, injection of MSCs into the annulus fibrosus or the nucleus pulposus of degenerated IVD resulted in significant improvements in disc health. LEVEL OF EVIDENCE: N/A.
STUDY DESIGN: In-vivo ovine model of intervertebral disc degeneration (IVD) to evaluate treatment with stem cells. OBJECTIVE: To determine if stem cells delivered to the nucleus pulposus (NP) or the annulus fibrosus (AF) of degenerated lumbar IVDs leads to improved indices of disc health. SUMMARY OF BACKGROUND DATA: Previous studies assessing the efficacy of stem cell injections into degenerated IVDs have reported positive findings. However, studies have been limited to small animals, targeting solely the NP, with short term follow-up. METHODS: Mesenchymal precursor cells (MSC) were obtained from the iliac crest of 8-week-old sheep. IVD degeneration was induced by postero-lateral annulotomy at three lumbar levels in eight 2-year-old sheep. Six months later, each degenerated IVD was randomized to one of three treatments: Injection of MSC into (i) previously incised AF (AFI), (ii) NP (NPI), or (iii) no injection (negative control, NC). The adjacent IVD received injection of phosphate buffered saline into NP (positive control, PC). Radiographs and magnetic resonance imaging scans were obtained at baseline, 6, 9, and 12 months. Discs were harvested at 12 months for biochemical and histological analyses. RESULTS:IVD degeneration was consistently observed postannulotomy, and characterized by reduced disc height index (DHI), disc height (DH), glycosaminoglycan (GAG) content, and increased grade of disc degeneration.Six months after stem cell injection, DHI and DH had recovered in AFI and NPI groups when compared with NC group (P < 0.01). Mean Pfirrmann grade improved from 3.25 to 2.67 (AFI group) and from 2.96 to 2.43 (NPI group). Mean histopathological grade improved for both AFI (P < 0.002) and NPI (P < 0.02) groups. Both AFI and NPI groups demonstrated spontaneous repair of the postero-lateral annular lesion. CONCLUSION: In this large animal model, injection of MSCs into the annulus fibrosus or the nucleus pulposus of degenerated IVD resulted in significant improvements in disc health. LEVEL OF EVIDENCE: N/A.
Authors: Lauren Scarfe; Nathalie Brillant; J Dinesh Kumar; Noura Ali; Ahmed Alrumayh; Mohammed Amali; Stephane Barbellion; Vendula Jones; Marije Niemeijer; Sophie Potdevin; Gautier Roussignol; Anatoly Vaganov; Ivana Barbaric; Michael Barrow; Neal C Burton; John Connell; Francesco Dazzi; Josefina Edsbagge; Neil S French; Julie Holder; Claire Hutchinson; David R Jones; Tammy Kalber; Cerys Lovatt; Mark F Lythgoe; Sara Patel; P Stephen Patrick; Jacqueline Piner; Jens Reinhardt; Emanuelle Ricci; James Sidaway; Glyn N Stacey; Philip J Starkey Lewis; Gareth Sullivan; Arthur Taylor; Bettina Wilm; Harish Poptani; Patricia Murray; Chris E P Goldring; B Kevin Park Journal: NPJ Regen Med Date: 2017-10-19
Authors: Cindy C Shu; Margaret M Smith; Susan M Smith; Andrew J Dart; Christopher B Little; James Melrose Journal: Int J Mol Sci Date: 2017-05-12 Impact factor: 5.923
Authors: Stefan Stich; Anke Möller; Mario Cabraja; Jan Philipp Krüger; Sylvia Hondke; Michaela Endres; Jochen Ringe; Michael Sittinger Journal: Int J Mol Sci Date: 2018-07-28 Impact factor: 5.923
Authors: Cindy C Shu; Andrew Dart; Robin Bell; Christina Dart; Elizabeth Clarke; Margaret M Smith; Christopher B Little; James Melrose Journal: JOR Spine Date: 2018-10-10
Authors: Abbey A Thorpe; Frances C Bach; Marianna A Tryfonidou; Christine L Le Maitre; Fackson Mwale; Ashish D Diwan; Keita Ito Journal: JOR Spine Date: 2018-08-02
Authors: Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Sophie Boorman; Dawn M Elliott; Weiliam Chen; George R Dodge; Robert L Mauck; Neil R Malhotra; Lachlan J Smith Journal: Tissue Eng Part A Date: 2020-08-07 Impact factor: 3.845